Catatonia in Nodding Syndrome and Lorazepam Treatment
Conditions: Catatonia; Nodding SyndromeIntervention: Drug: LorazepamSponsors: Makerere University; University of Mississippi Medical CenterCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2015 Category: Research Source Type: clinical trials
Pharmacovigilance in Gerontopsychiatric Patients
Conditions: Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety DisordersInterventions: Drug: Phenobarbital; Drug: Phenytoin; Drug: Carbamazepine; Drug: Oxcarbazepine; Drug: Valproic Acid; Drug: Lamotrigine; Drug: Topiramate; Drug: Gabapentin; Drug: Levetiracetam; Drug: Pregabalin; Drug: Lacosamide; Drug: Clonazepam; Drug: Biperiden; Drug: Levomepromazine; Drug: Fluphenazine; Drug: Perphenazine; Drug: Perazine; Drug: Thioridazine; Drug: Haloperidol; Drug: Melperone; Drug: Pipamperone; Drug: Bromperi...
Source: ClinicalTrials.gov - January 5, 2015 Category: Research Source Type: clinical trials
EDG004 (Lorazepam Extended-release) Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Condition: Generalized Anxiety Disorder (GAD)Interventions: Drug: EDG004 (lorazepam extended-release); Drug: PlaceboSponsor: Edgemont Pharmaceuticals, LLCNot yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2014 Category: Research Source Type: clinical trials
